Product Name :
Anti-Influenza B Virus(Lesofavumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Influenza B Virus
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-Influenza B Virus(Lesofavumab Biosimilar) Antibody is a biosimilar antibody directed against Influenza B Virus.{{2676211-64-4} site|{2676211-64-4} Technical Information|{2676211-64-4} Formula|{2676211-64-4} supplier} | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Influenza B Virus | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-Influenza B Virus(Lesofavumab Biosimilar) Antibody is a biosimilar antibody directed against Influenza B Virus.
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{2169946-15-8} web|{2169946-15-8} Technical Information|{2169946-15-8} Data Sheet|{2169946-15-8} manufacturer} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.PMID:30000526 The actual dilution used must be determined empirically.